STORM Therapeutics Announces First Patient Dosed in Clinical Collaboration to Evaluate STC-15 in Combination with LOQTORZI® and Appointment of Atif Abbas, M.D., as Chief Medical Officer

STORM Therapeutics United Kingdom United States of America

View original content:https://www.prnewswire.co.uk/news-releases/storm-therapeutics-announces-first-patient-dosed-in-clinical-collaboration-to-evaluate-stc-15-in-combination-with-loqtorzi-and-appointment-of-atif-abbas-md-as-chief-medical-officer-302465721.html